Article Text

Download PDFPDF
Prioritising paediatric surveillance during the COVID-19 pandemic
  1. Shamez N Ladhani1,2,
  2. Zahin Amin-Chowdhury1,
  3. Gayatri Amirthalingam1,2,
  4. Alicia Demirjian3,4,5,
  5. Mary Elizabeth Ramsay1
  1. 1 Immunisation and Countermeasures Division, Public Health England Colindale, London, UK
  2. 2 Paediatric Infectious Diseases Research Group, St George's University of London (SGUL), London, United Kingdom
  3. 3 Healthcare-Associated Infection and Antimicrobial Resistance Department, Public Health England Colindale, London, United Kingdom
  4. 4 Paediatric Infectious Diseases and Immunology, Evelina London Children's Hospital, London, United Kingdom
  5. 5 Faculty of Life Sciences and Medicine, King's College, London, United Kingdom
  1. Correspondence to Dr Shamez N Ladhani, Immunisation and Countermeasures Department, Public Health England Colindale, London NW9 5EQ, UK; DrShamez{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Children may represent only a small proportion of confirmed cases of coronavirus disease 2019 (COVID-19) in the current pandemic, but they are at the centre of every paediatrician’s mind and the primary focus of their work. While much of the COVID-19 pandemic preparedness and response is rightly focused on adults, paediatricians should be reassured that children have not been forgotten. In the UK, the Royal College of Paediatrics and Child Health (RCPCH) has produced extensive guidance for paediatricians that are available online ( At the same time, Public Health England (PHE) provides regularly updated guidance for healthcare professionals, focusing particularly on infection control and testing for COVID-19 ( PHE is also working with National Health Service (NHS) and academic colleagues to answer important questions about childhood COVID-19, including the course of illness and outcomes in neonates and children, the risk of vertical transmission during pregnancy and the role of children in infection and disease transmission in the community.

Global COVID-19 situation

Coronaviruses typically cause mild upper respiratory tract infections, but they have been responsible for three major outbreaks associated with severe illness and death: severe acute respiratory syndrome (SARS) in 2002, Middle East respiratory syndrome (MERS) in 2012 and, now, COVID-19. Genomic analyses indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, originated in bats1 and was probably transmitted to humans through an intermediate host, most likely pangolins (scaly anteater-like mammals).2 The illness was first recognised in Wuhan, Hubei Province, China, in early December 2019, and spread rapidly across the continents, leading the World Health Organization (WHO) to declare COVID-19 a public health emergency of international concern (PHEIC) on 30 January 2020 and then a global pandemic on 12 March 2020. By 28 April 2020, there were >3.2 million COVID-19 cases and >225 000 deaths worldwide (

COVID-19 in the UK

In the …

View Full Text


  • Contributors SL wrote the first draft of the manuscript. All authors contributed equally to the content of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • Atoms
    Nick Brown